Hepatitis B virus-infected HepG2hNTCP cells serve as a novel immunological tool to analyze the antiviral efficacy of CD8+ T cells in vitro

Journal of Virology

Volumn 89, Issue 14, 2015, Pages 7433-7438

  Hoh, Alexander ^a,b   Heeg, Maximilian ^a   Ni, Yi ^c   Schuch, Anita ^a,b   Binder, Benedikt ^a   Hennecke, Nadine ^a   Blum, Hubert E ^a   Nassal, Michael ^a   Protzer, Ulrike ^d,e   Hofmann, Maike ^a   Urban, Stephan ^c,f   Thimme, Robert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Partner Site Munich   (Germany)

^f Heidelberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ADULT; ANALYSIS OF VARIANCE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRUS LOAD; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B VIRUS; IMMUNOLOGY; THEORETICAL MODEL;

HEPATITIS B VIRUS;

CD8-POSITIVE T-LYMPHOCYTES; CYTOLOGICAL TECHNIQUES; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; MODELS, THEORETICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84931052762     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00605-15     Document Type: Article

References (19)

1. Bertoletti A, Ferrari C. 2012. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61:1754-1764. http://dx.doi.org/10.1136/gutjnl-2011-301073.
2. Park SH, Rehermann B. 2014. Immune responses to HCV and other hepatitis viruses. Immunity 40:13-24. http://dx.doi.org/10.1016/j.immuni.2013.12.010.
3. Protzer U, Maini MK, Knolle PA. 2012. Living in the liver: hepatic infections. Nat Rev Immunol 12:201-213. http://dx.doi.org/10.1038/nri3169.
4. Schuch A, Hoh A, Thimme R. 2014. The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection. Front Immunol 5:258. http://dx.doi.org/10.3389/fimmu.2014.00258.
5. Wieland SF, Chisari FV. 2005. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79:9369-9380. http://dx.doi.org/10.1128/JVI.79.15.9369-9380.2005.
6. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99:15655-15660. http://dx.doi.org/10.1073/pnas.232137699.
7. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, Stindt J, Koniger C, Nassal M, Kubitz R, Sultmann H, Urban S. 2014. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146:1070-1083. http://dx.doi.org/10.1053/j.gastro.2013.12.024.
8. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049. http://dx.doi.org/10.7554/eLife.00049.
9. Garson JA, Grant PR, Ayliffe U, Ferns RB, Tedder RS. 2005. Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods 126:207-213. http://dx.doi.org/10.1016/j.jviromet.2005.03.001.
10. Gehring AJ, Xue SA, Ho ZZ, Teoh D, Ruedl C, Chia A, Koh S, Lim SG, Maini MK, Stauss H, Bertoletti A. 2011. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J Hepatol 55:103-110. http://dx.doi.org/10.1016/j.jhep.2010.10.025.
11. Jo J, Aichele U, Kersting N, Klein R, Aichele P, Bisse E, Sewell AK, Blum HE, Bartenschlager R, Lohmann V, Thimme R. 2009. Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 136:1391-1401. http://dx.doi.org/10.1053/j.gastro.2008.12.034.
12. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, Schreiber RD, Schlicht HJ, Huang SN, Chisari FV. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 152:3245-3253.
13. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. 2003. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77:68-76. http://dx.doi.org/10.1128/JVI.77.1.68-76.2003.
14. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. 1996. Intracellular inactivation of the hepatitisBvirus by cytotoxicTlymphocytes. Immunity 4:25-36. http://dx.doi.org/10.1016/S1074-7613(00)80295-2.
15. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829. http://dx.doi.org/10.1126/science.284.5415.825.
16. Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. 2010. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 184:287-295. http://dx.doi.org/10.4049/jimmunol.0902761.
17. Sun D, Nassal M. 2006. Stable HepG2-and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45:636-645. http://dx.doi.org/10.1016/j.jhep.2006.05.019.
18. + T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 80:3532-3540. http://dx.doi.org/10.1128/JVI.80.7.3532-3540.2006.
19. Maini MK, Boni C, Ogg GS, King AS, Reignat S, Lee CK, Larrubia JR, Webster GJ, McMichael AJ, Ferrari C, Williams R, Vergani D, Bertoletti A. 1999. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 117:1386-1396. http://dx.doi.org/10.1016/S0016-5085(99)70289-1.